Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose tolerance.
about
Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-AnalysisPathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes.Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
P2860
Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose tolerance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Efficacy and safety of low-dos ...... or impaired glucose tolerance.
@en
Efficacy and safety of low-dos ...... or impaired glucose tolerance.
@nl
type
label
Efficacy and safety of low-dos ...... or impaired glucose tolerance.
@en
Efficacy and safety of low-dos ...... or impaired glucose tolerance.
@nl
prefLabel
Efficacy and safety of low-dos ...... or impaired glucose tolerance.
@en
Efficacy and safety of low-dos ...... or impaired glucose tolerance.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of low-dos ...... or impaired glucose tolerance.
@en
P2093
Chisato Katoh
Daisuke Horiuchi
Hiroyuki Hanada
Jin Yokoyama
Ken Okumura
Naoyuki Sutoh
Shingo Sasaki
Takashi Echizen
Takashi Yokota
Takumi Higuma
P2860
P2888
P304
P356
10.1007/S00380-006-0951-Z
P577
2007-05-21T00:00:00Z